BioCryst Pharmaceuticals,Inc. (BCRX)

[Femto99]

ORLADEYO cost is similar to competitors

Results showed that over the six months, the mean cost for Haegarda ($226,989) was about $51,000 lower than for Takhzyro ($278,267).

https://angioedemanews.com/2020/05/13/takhzyro-haegarda-prophylactics-costs-unsustainable-preventive-hae-attacks-us-real-world-data/